Risk for Imminent Delivery in Preeclampsia Based on the sFlt-1/PlGF Ratio: Do We Need New Cut-Offs?

被引:0
|
作者
Enengl, Sabine [1 ]
Oppelt, Peter [1 ]
Stelzl, Patrick [1 ]
Scharnreitner, Iris [1 ]
Altmann, Reinhard [1 ]
Grienberger, Julia [1 ]
Hermann, Philipp [2 ]
Wagner, Helga [2 ,3 ]
Rezk-Fuereder, Marlene [4 ]
Damian, Ilinca [5 ]
Maghoerndl, Lena [1 ]
机构
[1] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Gynecol, Obstet & Gynecol Endocrinol, Altenberger Str 69, A-4040 Linz, Austria
[2] Johannes Kepler Univ Linz, Fac Med, Ctr Clin Res, Stat Consulting & Data Anal, Linz, Austria
[3] Johannes Kepler Univ Linz, Inst Appl Stat Med Stat & Biometry, Linz, Austria
[4] Johannes Kepler Univ Linz, Kepler Univ Hosp Linz, Expt Gynecol Obstet & Gynecol Endocrinol, Linz, Austria
[5] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Cardiac Vasc & Thorac Surg, Linz, Austria
关键词
preeclampsia; sFlt-1/PlGF; soluble fms-like tyrosine kinase-1; placental growth factor; time to delivery; GROWTH-FACTOR RATIO; EARLY-ONSET PREECLAMPSIA; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; ADVERSE OUTCOMES; PREGNANCY; WOMEN; DIAGNOSIS; EPIDEMIOLOGY; MANAGEMENT;
D O I
10.1055/a-2497-8104
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction It is still difficult to predict the outcome of preeclampsia and determine the individual procedure with regards to the time of birth. Cut-offs of the sFlt-1/PlGF ratio with a high risk for imminent delivery have been previously published and analyzed by our study group, but could not be confirmed. The aim of the current study is to re-evaluate the described cut-off values again in a new period of time. Materials and Methods We performed a retrospective analysis (IRB 1279/2020) including all preeclampsia patients delivering in our department over a 3-year period. Patients were divided into 2 groups - gestational week 24+0-33+6 with an s-Flt1/PlGF > 655.2 and 34+0-37+0 weeks with an sFlt-1/PlGF > 201 and were compared with preeclampsia patients of the same weeks with sFlt-1/PlGF values below the described cut-offs. Correlation between sFlt-1/PlGF ratio and time to delivery was assessed. Results The association between sFlt-1/PlGF above the threshold and delivery within 48 h is significant for the high ratio early group (p < 0.01) but not for the high ratio late group (p = 0.62). In the early group, 60% of patients with sFlt-1/PlGF > 655.2 but only 8% in the low ratio group delivered within 48 h. In both the early and the late preeclampsia group, a high number of patients remained pregnant even though they showed elevated ratios. Conclusion High sFlt-1/PlGF ratios seem to correlate with a shorter pregnancy duration to some extent. Nevertheless, not all patients need to be delivered within 48 h, so the decision should never be based on the laboratory test alone.
引用
收藏
页码:190 / 199
页数:10
相关论文
共 50 条
  • [31] sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
    Kamil Pluta
    Marcin Januszewski
    Laura Ziuzia-Januszewska
    Michał Kudan
    Maria Suchocka
    Kinga Kuśmierczuk
    Tadeusz Issat
    Artur J. Jakimiuk
    BMC Pregnancy and Childbirth, 24
  • [32] Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
    Schlembach, Dietmar
    Hund, Martin
    Schroer, Annabel
    Wolf, Cyrill
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [33] An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia
    Stolz, Myriam
    Zeisler, Harald
    Heinzl, Florian
    Binder, Julia
    Farr, Alex
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 11 : 54 - 60
  • [34] Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/PlGF Ratio in Singleton Pregnancies
    Herraiz, Ignacio
    Llurba, Elisa
    Verlohren, Stefan
    Galindo, Alberto
    FETAL DIAGNOSIS AND THERAPY, 2018, 43 (02) : 81 - 89
  • [35] Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
    Velegrakis, Alexandros
    Kouvidi, Elisavet
    Fragkiadaki, Persefoni
    Sifakis, Stavros
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 52 (04)
  • [36] Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia
    Verlohren, Stefan
    Brennecke, Shaun P.
    Galindo, Alberto
    Karumanchi, S. Ananth
    Mirkovic, Ljiljana B.
    Schlembach, Dietmar
    Stepan, Holger
    Vatish, Manu
    Zeisler, Harald
    Rana, Sarosh
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2022, 27 : 42 - 50
  • [37] sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
    Pluta, Kamil
    Januszewski, Marcin
    Ziuzia-Januszewska, Laura
    Kudan, Michal
    Suchocka, Maria
    Kusmierczuk, Kinga
    Issat, Tadeusz
    Jakimiuk, Artur J.
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [38] Predictive Value of the sFlt-1: PlGF Ratio in Women With Suspected Preeclampsia EDITORIAL COMMENT
    Zeisler, Harald
    Llurba, Elisa
    Chantraine, Frederic
    Vatish, Manu
    Staff, Anne Cathrine
    Sennstrom, Maria
    Olovsson, Matts
    Brennecke, Shaun P.
    Stepan, Holger
    Allegranza, Deirdre
    Dilba, Peter
    Schoedl, Maria
    Hund, Martin
    Verlohren, Stefan
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (05) : 273 - 274
  • [39] Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam
    Trung Huu Nguyen
    Thanh Cong Bui
    Tuan Minh Vo
    Quan Minh Tran
    Loan Thi-Thanh Luu
    Tai Duy Nguyen
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 14 : 37 - 42
  • [40] Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
    Dietmar Schlembach
    Martin Hund
    Annabel Schroer
    Cyrill Wolf
    BMC Health Services Research, 18